All Phenotypes Pkn2<tm1c(KOMP)Wtsi> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Pkn2^{tm1c(KOMP)Wtsi}/Pkn2^{tm1c(KOMP)Wtsi} Tg(Tek-cre)12Flv/0	involves: C3H * C57BL/6 * C57BL/6N	MGI:5912009
cn2	Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ Pkn2^{tm1c(KOMP)Wtsi}/Pkn2^{tm1c(KOMP)Wtsi}	involves: C57BL/6N * C57BL/6NTac	MGI:5912012
cn3	Pkn2^{tm1c(KOMP)Wtsi}/Pkn2^{tm1c(KOMP)Wtsi} Tg(Tagln-cre)1Jjl/0	involves: C57BL/6N * FVB/N	MGI:5912010

Allelic Composition	Pkn2^{tm1c(KOMP)Wtsi}/Pkn2^{tm1c(KOMP)Wtsi} Tg(Tek-cre)12Flv/0
Genetic Background	involves: C3H * C57BL/6 * C57BL/6N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pkn2^{tm1c(KOMP)Wtsi} mutation (0 available); any Pkn2 mutation (84 available)
Tg(Tek-cre)12Flv mutation (1 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

normal phenotype

no abnormal phenotype detected ( J:229595 )

• viable with no overt vascular phenotypes

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

embryo

increased embryonic tissue cell apoptosis ( J:229595 )

• following tamoxifen treatment

abnormal embryo turning ( J:229595 )

• tamoxifen treatment at E7.5 results in axial turning defects in most mice at E9.5

abnormal embryo morphology ( J:229595 )

• tamoxifen treatment at E6.5 reproduces the gross phenotypes seen in germline null mice

absent pharyngeal arches ( J:229595 )

• loss of branchial arches following tamoxifen treatment

abnormal mesoderm morphology ( J:229595 )

• decrease in cephalic mesoderm at E10 in embryos treated with tamoxifen at E8.0

abnormal mesenchyme morphology ( J:229595 )

• tamoxifen treatment at E6.5 results in collapse of the mesenchyme

cardiovascular system

abnormal vascular development ( J:229595 )

• vascular disintegration following tamoxifen treatment

hemorrhage ( J:229595 )

• at E10 in embryos treated with tamoxifen at E8.0

cellular

abnormal mitosis ( J:229595 )

• in MEFs tamoxifen treatment results in an accumulation of cells in G1/G0 and loss of S-phase and mitotic cells

decreased mitotic index ( J:229595 )

• in pharyngeal mesodermal cells at E10, 48h past tamoxifen treatment

• however mitotic indices in branchial arch, neural tube, and heart cells are similar to controls

increased embryonic tissue cell apoptosis ( J:229595 )

• following tamoxifen treatment

decreased fibroblast proliferation ( J:229595 )

• reduced MEF cell growth following tamoxifen treatment

• however, tamoxifen treatment of embryonic stem cells does not alter cell growth

craniofacial

absent pharyngeal arches ( J:229595 )

• loss of branchial arches following tamoxifen treatment

Allelic Composition	Pkn2^{tm1c(KOMP)Wtsi}/Pkn2^{tm1c(KOMP)Wtsi} Tg(Tagln-cre)1Jjl/0
Genetic Background	involves: C57BL/6N * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pkn2^{tm1c(KOMP)Wtsi} mutation (0 available); any Pkn2 mutation (84 available)
Tg(Tagln-cre)1Jjl mutation (0 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

lethality, incomplete penetrance ( J:229595 )

cardiovascular system

cardiac hypertrophy ( J:229595 )

• in survivors

respiratory system

overexpanded pulmonary alveolus ( J:229595 )

• alveolar enlargement in survivors

pulmonary fibrosis ( J:229595 )

• in survivors

growth/size/body

cardiac hypertrophy ( J:229595 )

• in survivors

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 05/14/2024 MGI 6.23